Addition, the GSK1016790A-induced increase in nNOS protein level and activity and the inhibition of CAT
Addition, the GSK1016790A-induced increase in nNOS protein level and activity and the inhibition of CAT and GSH-Px activities had been significantly blocked by HC-067047 (Figure 3). These outcomes additional confirmed…